Yang Kun, Hu Jian-Kun
Department of Gastrointestinal Surgery, West China Hospital, Sichuan University, Chengdu 610041, China.
Institute of Gastric Cancer, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China.
Transl Gastroenterol Hepatol. 2017 Apr 28;2:36. doi: 10.21037/tgh.2017.04.02. eCollection 2017.
Chinese populations have many demographic similarities to Korean populations. However, the long-term survival rates of gastric cancer patients in China are still not satisfactory when compared with Korea, especially for the advanced cases. In this article, we discuss about the similarity and difference of gastric cancer treatment in terms of screening, surgical approach, stomach resection, digestive tract reconstruction, lymphadenectomy, harvested lymph nodes, operative morbidity and mortality, postoperative chemotherapy as well as follow-up between China and Korea. Given that a variety of factors ranging from tumor characteristics to different treatment strategies are seen between the two countries, the reasons accounting for the differences in survival should be focused and the corresponding strategy should be considered and finally promote to improve the prognosis of gastric cancer.
中国人群在人口统计学方面与韩国人群有许多相似之处。然而，与韩国相比，中国胃癌患者的长期生存率仍不尽人意，尤其是晚期病例。在本文中，我们探讨了中国和韩国在胃癌治疗方面的异同，包括筛查、手术方式、胃切除、消化道重建、淋巴结清扫、获取的淋巴结、手术并发症和死亡率、术后化疗以及随访等方面。鉴于两国之间存在从肿瘤特征到不同治疗策略等多种因素，应关注导致生存差异的原因，并考虑相应的策略，最终促进改善胃癌的预后。
